Sustainability
A commitment to the communities we serve runs through everything we do.
We aspire to support people to lead longer, healthier lives, and sustain the environments around them.
Contributing to society
We are committed to contributing to the United Nations Sustainable Development Goals (SDGs) as part of our global Shionogi family.
We have identified five UN SDGs that we can specifically help to achieve, outlined in the icons below. These include ensuring good health and wellbeing; decent work and economic growth; industry, innovation and infrastructure; responsible consumption and production; and partnership for the goals.
We do this through striving to address material issues such as:
- protect people from infectious diseases,
- extend healthy lifespans, and
- deliver healthcare solutions at prices that match their value.
You can read about all the material issues SHIONOGI is looking to address on the global website:
https://www.shionogi.com/global/en/company/strategy/important-issues.html
For example, we are proud to play a leading role in the fight against antimicrobial resistance (AMR). Below you can find more details about how we are taking this work forward.
Our role in the fight against AMR
- invest a proportion of our pharmaceutical revenues in relevant anti-infectives research and development.
- are expanding our capabilities – Shionogi has entered into a definitive agreement to acquire Qpex Biopharma, Inc. Qpex’s pipeline and its capabilities will accelerate our efforts to develop new antibiotic treatments to address antimicrobial resistance. We are also working in close partnership with organisations like Sobi to improve access for patients.
- are a signatory company of the Davos Declaration on combating AMR, which calls for collective action to create a sustainable and predictable market for antibiotics, vaccines and diagnostics.
- take action to help reduce overuse of antibiotics, such as securing landmark deals in European countries (including the UK and Sweden) that break the links between the payments received and the number of antibiotics prescribed.
- are a sponsor and contributor to the Vivli AMR Register project which sees pharmaceutical companies facilitate access to resistance surveillance data on their antibiotics
- are proud that globally, Shionogi works with the Global Antibiotic Research and Development Partnership (GARDP) and the Clinton Health Access Initiative (CHAI), to improve and accelerate access to newer antibiotics for countries around the world.
Contributing to our environment
We have committed to reducing CO2 emissions year on year and increasing our plastic reuse and recycling by 2030. We are proud that in 2023, for the second year in a row, Shionogi & Co., Ltd. was recognised on the prestigious CDP "A List", recognising our leadership in corporate transparency and performance on Climate Change and Water Security.
You can read more about our progress in this area on our global website at the link below:
Communication Barrier Free: Enhancing access for hearing-impaired people
Medical appointments can be daunting for anyone. Clear communication from healthcare providers can ease worries and ensure quality care. But imagine facing barriers to this communication due to hearing impairment. With millions worldwide affected by hearing issues, removing these obstacles is crucial.
Our Communication Barrier Free corporate and social responsibility initiative empowers healthcare professionals to communicate effectively with the deaf and hard of hearing. By working closely with stakeholders including charities and universities, we're bridging the gap in healthcare accessibility through education and support. Please check out more information about our activities from Communication Barrier Free website - and our manga-style booklet “Are you familiar with hearing impairment?”.
Our efforts continue beyond there. We're extending support beyond healthcare settings to communities worldwide.
Watch this short film to see our efforts around the globe:
Our governance
At the links below you can find more information on our governance:
References
- 1European Centre for Disease Prevention and Control: https://www.ecdc.europa.eu/en/news-events/eaad-2022-launch (accessed 19.09.23)